Reducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program
Reducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program
批准号:
10594560
负责人:
Andrea Zawacki Beaton
金额:
$24.24万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2027-02-28
关键词:
AddressAdvisory CommitteesAfrica South of the SaharaAfricanCaringChildClinical TrialsCollaborationsCountryDegree programDiseaseDoctor of PhilosophyE-learningEarly DiagnosisEducational workshopEnsureFellowshipFundingGenderGenerationsGoalsGrantGuidelinesHealthHeartHospitalsIncomeInstitutionKnowledgeLongevityMedical centerMedicineMentorsPediatric HospitalsPersonsPoliciesResearchResearch ActivityResearch PersonnelResearch TrainingResourcesRheumatic Heart DiseaseTrainingTraining ActivityTraining ProgramsTraining SupportTranslatingUgandaUnited States National Institutes of HealthUniversitiesVisionWomanburden of illnesscareer developmentexperienceheart disease preventionimprovedinnovationlow and middle-income countriesmedical schoolsnext generationparityprofessorprogramsrecruitsexsuccesswebinar
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This application seeks funding for a D43 training grant to support a world-first rheumatic heart disease
(RHD) research training program in Uganda. There has been little innovation globally in RHD prevention,
early detection, and management since the mid-1900’s. Additionally, the majority of evidence guiding
current practice was generated in high-income countries and may not translate directly to the contemporary
burden of disease in low- and middle-income countries (LMICs). The Impact Mentored Research-Training
Program will leverage existing resources and ongoing RHD clinical trials from a decade-long RHD research
and training collaboration between Makerere University, the Uganda Heart Institute (UHI), Cincinnati
Children’s Hospital Medical Centre (CCHMC) and Children’s National Hospital (CNH) to build capacity to
tackle RHD where the burden is the highest. Our overarching objective is to equip and nurture emerging
research leaders and professional scholars in Uganda to generate high-quality contemporary evidence on
RHD across the lifespan and to create an enduring research training center on the African continent that
will rapidly advance progress towards the elimination of the disease in a generation; a bold, but achievable
goal. This application will provide critical support for the training, and research activities needed to realize
this vision. The program will be led by Dr. Nelson Sewankambo, a Professor of Medicine
and Former Dean of the Makerere University School of medicine, who has led several NIH and non-NIH
research capacity building grants in Uganda and sub-Saharan Africa. Co-directing this program are the co-
Directors of the Rheumatic Heart Disease Research Collaborative in Uganda (RRCU), Drs. Emmy Okello
(UHI) and Andrea Beaton (CCHMC). Long-term degree training at Master’s, PhD and Career development
fellowship levels will be offered, with primary coursework to occur in Uganda at MakCHS. CNH will provide
both e-learning seminar and in-person immersive experience in the US to strengthen clinical trials capacity
and improve trainee’s knowledge of gender parity and sex- and gender considerations in health research.
Additionally, recruitment will target trainees from the regional centers to build National RHD capacity and
ensure at least 50% of our trainees are women. Short-term trainings, seminars, webinars and workshops
will be offered to degree and non-degree trainees to further strengthen institutional and national RHD-
research capacity and to identify promising candidates for degree programs. A Steering Committee and
the Training Advisory Committee (TAC) comprised of leading researchers with expertise in our objectives
will both offer expert advice to the Impact Directors to ensure success of the trainees and the overall
program by producing high-quality and locally relevant research. This success will translate into improving
guidelines and policies for RHD care in Uganda and the region, training the next generation of excellent
African researchers to address RHD prevention, early detection, and management.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A non-inferiority randomized trial. (GOALIE)
-
批准号:10571212
-
项目类别:
-
资助金额:$191.31万
-
财政年份:2023
-
负责人:Andrea Zawacki Beaton
-
依托单位:
Reducing the Impact of Rheumatic Heart Disease across the Life Span: The Impact Program
-
批准号:10469186
-
项目类别:
-
资助金额:$24.41万
-
财政年份:2022
-
负责人:Andrea Zawacki Beaton
-
依托单位:
Accelerating Delivery of rheumatic heart disease preventive iNterventions in Uganda (ADUNU)
-
批准号:10500950
-
项目类别:
-
资助金额:$68.03万
-
财政年份:2022
-
负责人:Andrea Zawacki Beaton
-
依托单位:
海外基金